Overview
Doximity, Inc., based in the United States, operates primarily in the healthcare technology sector. Established as a professional network for physicians, the company has significantly expanded its reach within the medical community. Doximity offers an array of digital tools tailored for medical professionals which includes features for secure communication, telehealth, and career management. Notably, its platform enables doctors to connect with colleagues, participate in professional development, and manage patient referrals more efficiently. As a key project, Doximity has launched Doximity Dialer and Clinician Matching System to enhance doctor-patient interactions and streamline the clinician recruitment process. These initiatives reflect the company's ongoing commitment to leverage technology in improving healthcare delivery.
AI+ Ask Fintel’s AI assistant about Doximity, Inc..
Thinking about good questions…
Basic Stats
The share price of Doximity, Inc. as of September 5, 2025 is $69.34 / share. This is an increase of 2.06% from the prior week. The market cap (or net worth) of Doximity, Inc. as of September 5, 2025 is $12,997.98 MM.
The Factor Analysis chart (below right) shows a view of Doximity, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 12,997.98 MM |
| EV | 12,862.60 MM |
| Shares Out. | 187.45 MM |
| Earnings Date | |
| EPS (TTM) | 1.25 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 2.00 MM |
| Short Interest | 4.36 MM |
| Short Float | 3.27 % |
| Days to Cover | 5.91 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 94.26 % |
| Volatility (1 yr) | 0.68 |
| Beta | 1.94 |
| Sharpe Ratio (1 yr) | 1.32 |
| Sortino Ratio (1 yr) | 3.04 |
| PE Ratio | 55.29 |
| Price/Book | 12.68 |
| Price/TBV | 13.89 |
| Book/Market | 0.08 |
| EBIT/EV | 0.02 |
| EBIT(3yr avg)/EV | 0.02 |
| ROA | 0.22 |
| ROE | 0.26 |
| ROIC | 0.23 |
| CROIC | 0.02 |
| OCROIC | 0.28 |
| Implied Volatility | 33.07 % |
| Put/Call OI Ratio | 1.00 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Doximity, Inc. is $69.70. The forecasts range from a low of $55.55 to a high of $84.00. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Doximity, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-06 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2022-11-11 | Wells Fargo | Overweight | Maintains | |
| 2022-10-31 | Wells Fargo | Overweight | Initiate | |
| 2022-10-24 | Evercore ISI Group | In-Line | Initiate | |
| 2022-10-13 | BTIG | Neutral | Initiate | |
| 2022-09-16 | Keybanc | Sector Weight | Initiate | |
| 2022-09-07 | Truist Securities | Hold | Initiate | |
| 2022-08-08 | Goldman Sachs | Buy | Maintains | |
| 2022-08-05 | Piper Sandler | Overweight | Maintains | |
| 2022-08-05 | Canaccord Genuity | Buy | Maintains | |
| 2022-08-05 | B of A Securities | Neutral | Underperform | Downgrade |
| 2022-07-29 | Berenberg | Buy | Initiate | |
| 2022-07-28 | Berenberg | Buy | Initiate | |
| 2022-05-19 | Piper Sandler | Overweight | Maintains | |
| 2022-05-19 | Goldman Sachs | Buy | Maintains | |
| 2022-05-18 | SVB Leerink | Outperform | Maintains | |
| 2022-05-18 | Raymond James | Outperform | Maintains | |
| 2022-05-18 | Needham | Buy | Maintains | |
| 2022-05-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-18 | Jefferies | Buy | Maintains | |
| 2022-05-18 | Guggenheim | Buy | Maintains | |
| 2022-05-18 | Baird | Outperform | Maintains | |
| 2022-04-07 | Guggenheim | Buy | Initiate | |
| 2022-04-04 | B of A Securities | Neutral | Initiate | |
| 2022-03-23 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-11 | Goldman Sachs | Buy | Initiate | |
| 2022-02-09 | Raymond James | Outperform | Maintains | |
| 2022-02-09 | Needham | Buy | Maintains | |
| 2021-12-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-12-14 | JP Morgan | Neutral | Underweight | Downgrade |
| 2021-12-02 | Jefferies | Buy | Initiate | |
| 2021-11-17 | Baird | Outperform | Initiate | |
| 2021-11-10 | SVB Leerink | Outperform | Maintains | |
| 2021-11-10 | Raymond James | Outperform | Maintains | |
| 2021-11-10 | Needham | Buy | Maintains | |
| 2021-08-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-08-26 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-08-11 | Raymond James | Outperform | Maintains | |
| 2021-07-19 | William Blair | Outperform | Initiate | |
| 2021-07-19 | SVB Leerink | Outperform | Initiate | |
| 2021-07-19 | Raymond James | Outperform | Initiate | |
| 2021-07-19 | Piper Sandler | Overweight | Initiate | |
| 2021-07-19 | Needham | Buy | Initiate | |
| 2021-07-19 | Morgan Stanley | Equal-Weight | Initiate | |
| 2021-07-19 | JP Morgan | Overweight | Initiate | |
| 2021-07-19 | Goldman Sachs | Neutral | Initiate | |
| 2021-07-19 | Canaccord Genuity | Buy | Initiate | |
| 2023-02-10 | Wells Fargo | Overweight | Maintains | |
| 2023-02-10 | Canaccord Genuity | Buy | Maintains | |
| 2023-02-10 | Needham | Buy | Reiterate | |
| 2023-02-17 | JP Morgan | Underweight | Maintains | |
| 2023-05-17 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-05-17 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2023-05-17 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2023-05-17 | Needham | Buy | Buy | Reiterate |
| 2023-05-01 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2023-06-05 | Truist Securities | Hold | Hold | Maintains |
| 2023-06-07 | Canaccord Genuity | Buy | Buy | Reiterate |
| 2023-06-07 | Needham | Buy | Buy | Reiterate |
| 2023-09-05 | Canaccord Genuity | Buy | Buy | Maintains |
| 2023-08-09 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-09 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2023-08-09 | Guggenheim | Buy | Neutral | Downgrade |
| 2023-08-09 | Raymond James | Outperform | Outperform | Maintains |
| 2023-08-09 | Needham | Buy | Hold | Downgrade |
| 2023-11-10 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2024-02-09 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-03 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2023-08-11 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-10 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-01-02 | B of A Securities | Underperform | Neutral | Upgrade |
| 2024-03-15 | JP Morgan | Underweight | Underweight | Maintains |
| 2024-05-17 | Needham | Hold | Reiterate | |
| 2024-05-17 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-02-09 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-23 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2024-02-26 | Leerink Partners | Market Perform | Initiate | |
| 2024-01-23 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-04-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-04-25 | JP Morgan | Underweight | Neutral | Upgrade |
| 2024-07-18 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2024-08-14 | Truist Securities | Hold | Hold | Reiterate |
| 2024-08-09 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-08-09 | Needham | Hold | Buy | Upgrade |
| 2024-08-09 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2025-07-09 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2024-11-08 | Raymond James | Outperform | Outperform | Reiterate |
| 2024-11-08 | Wells Fargo | Underweight | Equal-Weight | Upgrade |
| 2024-11-08 | Keybanc | Sector Weight | Overweight | Upgrade |
| 2024-08-09 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-08-09 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-02-07 | Needham | Buy | Buy | Maintains |
| 2024-11-14 | Truist Securities | Hold | Hold | Maintains |
| 2024-11-14 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2025-02-07 | Leerink Partners | Market Perform | Outperform | Upgrade |
| 2024-11-15 | Goldman Sachs | Neutral | Initiate | |
| 2024-11-21 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-05-16 | Raymond James | Outperform | Outperform | Maintains |
| 2025-05-16 | Truist Securities | Hold | Hold | Maintains |
| 2025-05-16 | Mizuho | Neutral | Neutral | Maintains |
| 2025-02-07 | Raymond James | Outperform | Outperform | Reiterate |
| 2025-02-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-07 | Canaccord Genuity | Hold | Hold | Maintains |
| 2024-10-07 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-11-13 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2024-12-04 | Mizuho | Neutral | Initiate | |
| 2024-10-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-10-30 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2024-08-19 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-09-17 | Baird | Outperform | Outperform | Maintains |
| 2025-02-10 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-02-10 | Mizuho | Neutral | Neutral | Maintains |
| 2024-11-11 | Barclays | Overweight | Overweight | Maintains |
| 2025-04-16 | Keybanc | Overweight | Overweight | Maintains |
| 2025-01-06 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-12-20 | Stephens & Co. | Equal-Weight | Initiate | |
| 2024-08-20 | Canaccord Genuity | Buy | Buy | Maintains |
| 2025-04-24 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-13 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-15 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2025-08-08 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-08 | Raymond James | Outperform | Outperform | Maintains |
| 2025-01-08 | Keybanc | Overweight | Overweight | Maintains |
| 2025-04-10 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-17 | Truist Securities | Hold | Hold | Maintains |
| 2025-05-16 | Needham | Buy | Buy | Maintains |
| 2025-06-02 | BTIG | Neutral | Buy | Upgrade |
| 2025-06-25 | B of A Securities | Neutral | Neutral | Maintains |
| 2025-08-08 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-07-14 | Keybanc | Overweight | Overweight | Maintains |
| 2025-05-16 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-05-20 | Baird | Outperform | Outperform | Maintains |
| 2025-05-27 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-08-11 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-08-04 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-21 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-08-08 | Needham | Buy | Buy | Maintains |
